Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide in Children With High Grade Glioma
NCT00028795Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Dec 2002
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of temozolomide in high-grade glioma (HGG), diffuse intrinsic pontine glioma (DIPG), sponsored by Children's Oncology Group. Started Dec 2002; status: completed.
02
Drugs
temozolomide
03
Conditions
high-grade glioma (HGG)diffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT00028795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028795.